Wellington Partners has led a €7.5m series-A funding round for ImevaX, a German biotech specialising in vaccines for the pathogens of chronic infectious diseases.
Sale of parent company of specialist outdoor brands Rab and Lowe Alpine is the firm’s third exit this year
Energy sector investor prepares to raise EUR 350m for Article 9 fund targeting renewable, clean tech businesses
US sponsor to become new majority owner; company achieved its objectives more than a year in advance
OMERS Private Equity to retain 25% stake in the French calibration laboratories provider